Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783703 · ClinicalTrials.gov registry record · NA
Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility Study
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02783703 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT02783703, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study team will investigate the racial differences in the metabolic and clinical responses to Medium chain triglycerides (MCT) between African American and Caucasian American subjects.
Interventions
- DIETARY_SUPPLEMENT Medium chain triglycerides (MCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-04-28 |
| Est. Completion | 2018-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02783703
The ClinicalTrials.gov registry entry for NCT02783703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medium chain triglycerides (MCT) is the first listed.
NCT02783703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02783703 about?
NCT02783703 is a clinical study titled "Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility Study". The study team will investigate the racial differences in the metabolic and clinical responses to Medium chain triglycerides (MCT) between African American and Caucasian American subjects.
What is the current status of trial NCT02783703?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-04-28. Estimated completion is 2018-06-20.
What interventions are being tested in trial NCT02783703?
The interventions under investigation include: Medium chain triglycerides (MCT) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02783703?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.